tm
Seeing Is Believing
tm
Seeing Is Believing
INKT is currently covered by 1 analysts with an average price target of $35. This is a potential upside of $7.5 (187.36%) from yesterday's end of day stock price of $12.18.
Mink Therapeutics's activity chart (see below) currently has 22 price targets and 22 ratings on display. The stock rating distribution of INKT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 250.5 days.
Highest price target for INKT is $35, Lowest price target is $35, average price target is $35.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 01-Apr-2026.
Currently out of the existing stock ratings of INKT, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Apr-2026
$35
$22.82 (187.36%)
$35
5 months 27 days ago
(01-Apr-2026)
10/14 (71.43%)
$24.43 (231.13%)
187
Buy Since 10-Nov-2021
$4
$-8.18 (-67.16%)
$80
1 years 10 months 13 days ago
(15-Nov-2024)
0/3 (0%)
$-3.54 (-46.95%)
$30
$17.82 (146.31%)
$300
3 years 6 months 6 days ago
(22-Mar-2023)
1/2 (50%)
$9.1 (43.54%)
92
Buy Since 09-Nov-2021
$7
$-5.18 (-42.53%)
4 years 4 months 17 days ago
(11-May-2022)
1/2 (50%)
$-5.9 (-45.74%)
881
What is INKT (Mink Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on INKT (Mink Therapeutics)?
Which analyst has the most public recommendations on INKT (Mink Therapeutics)?
Which analyst is the currently most bullish on INKT (Mink Therapeutics)?
Which analyst is the currently most reserved on INKT (Mink Therapeutics)?
